Trial intelligence / Profile preview

Microplasmin for acute iliofemoral DVT

NCT00428129Phase 2Terminated

Sponsor
Oxurion
Start
Mar 2007
Primary completion
Jul 2008
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 2 trial of ocriplasmin in deep vein thrombosis (DVT), sponsored by Oxurion. Started Mar 2007; status: terminated.

02

Drugs

ocriplasmin
03

Conditions

deep vein thrombosis (DVT)

Beyond the preview

Go deeper on NCT00428129.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00428129.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call